{"id":"W2032597812","doi":"10.1016/j.ejca.2009.05.008","title":"A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours","year":2009,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Hospital for Sick Children; McMaster University Medical Centre; University of British Columbia; Alberta Children's Hospital; SickKids Foundation","funders":"","keywords":"PDGFRA; Imatinib; Medicine; Pharmacokinetics; Refractory (planetary science); Gastroenterology; Immunohistochemistry; Cerebrospinal fluid; Internal medicine; Central nervous system; Vomiting; Imatinib mesylate; Pathology; Oncology; GiST; Stromal cell; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008169848,0.0009148015,0.001193631,0.000238856,0.0004903033,0.0003949101,0.0008324105,0.000606234,0.002049509],"category_scores_gemma":[0.000569251,0.0001880173,0.0004641266,0.000714448,0.0006101354,0.0001639677,0.0002573782,0.0009696517,0.0002746691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004281433,"about_ca_system_score_gemma":0.008913822,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1535914,"about_ca_topic_score_gemma":0.3430802,"domain_scores_codex":[0.999612,0.0001306159,0.00001288238,0.00004560984,0.0001366986,0.00006223623],"domain_scores_gemma":[0.999592,0.00003825414,0.00008142247,0.00001282404,0.00007523593,0.0002003886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2141548,0.01619432,0.152478,0.004397865,0.003600019,0.004755468,0.00179859,0.01223767,0.1432482,0.0012016,0.02894163,0.4169917],"study_design_scores_gemma":[0.1433839,0.2115581,0.5513691,0.0002964483,0.002139197,0.007005818,0.0005465049,0.003754417,0.02418119,0.00038798,0.055265,0.0001122573],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901737,0.004792669,0.0003815528,0.0004435105,0.00003066952,0.001045484,0.001085348,0.00004516256,0.002001875],"genre_scores_gemma":[0.9816421,0.006516643,0.003255896,0.0007694858,0.00006954619,0.001300059,0.004049439,0.00003068767,0.002366107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8464086,"threshold_uncertainty_score":0.3053948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01134035174256869,"score_gpt":0.2708131302075913,"score_spread":0.2594727784650226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}